Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapy.
Journal: Journal of bone oncology
Published: January 07, 2026
N-cadherin in osteolineage cells modulates stromal support of tumor growth.
Journal: Journal of bone oncology
Published: November 05, 2020
Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases.
Journal: Molecular cancer therapeutics
Published: October 28, 2020
Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment.
Journal: The Journal of clinical investigation
Published: October 20, 2020
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia.
Journal: JCI insight
Published: March 13, 2019
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.
Journal: Cancer research
Published: May 03, 2017
Antagonizing Integrin β3 Increases Immunosuppression in Cancer.
Journal: Cancer research
Published: September 23, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026